These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14405462)

  • 1. Statement of the A.M.A. to the Subcommittee on health and safety, Committee on interstate and foreign commerce, House of Representatives. H.R. 5260, Federal Hazardous Substances Labeling Act March 14, 1960.
    HUNTER OB
    J Am Med Assoc; 1960 May; 173():263-5. PubMed ID: 14405462
    [No Abstract]   [Full Text] [Related]  

  • 2. The Federal Hazardous Substances Labeling Act. Preparation of precautionary labeling in conformance with the act and its regulations.
    NALE TW
    Arch Environ Health; 1962 Mar; 4():239-46. PubMed ID: 14478271
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of the federal hazardous substances labeling act.
    KERLAN I; MOLINAS S
    New Physician; 1962 Mar; 11():72-6. PubMed ID: 14455271
    [No Abstract]   [Full Text] [Related]  

  • 4. Statement by the American Society for Medcial Technology in consideration of the proposed recombinant DNA legislation: submitted to the Senate Subcommittee on Health of the Human Resource Committee and to the House Subcommittee on Health of the Interstate Foreign Commerce Committee. September 7, 1977.
    Am J Med Technol; 1978 Jan; 44(1):66. PubMed ID: 623146
    [No Abstract]   [Full Text] [Related]  

  • 5. STATEMENT by Edward J. McCormick on medical research and progress before House Committee on Interstate and Foreign Commerce.
    J Am Med Assoc; 1953 Oct; 153(8):730-1. PubMed ID: 13096286
    [No Abstract]   [Full Text] [Related]  

  • 6. STATEMENT by Paul Wermer on cancer diagnosis, treatment, and research before House Committee on Interstate and Foreign Commerce.
    J Am Med Assoc; 1953 Oct; 153(8):731-2. PubMed ID: 13096287
    [No Abstract]   [Full Text] [Related]  

  • 7. Testimony of George E. Hardy, Jr., M. D., M. P. H. Health Officer, Jefferson County Department of Health. Before the House Subcommittee on Public Health and Environment of the House Committee on Interstate and Foreign Commerce, U. S. House of Representatives, Washington, D. C. on Thursday, April 27, 1972.
    Hardy GE
    J Med Assoc State Ala; 1972 Jul; 42(1):12 passim. PubMed ID: 5044794
    [No Abstract]   [Full Text] [Related]  

  • 8. [Labeling of toxic products of foreign origin].
    HADENGUE A; CAVIGNEAUX A
    Arch Mal Prof; 1960; 21():45-6. PubMed ID: 13830759
    [No Abstract]   [Full Text] [Related]  

  • 9. The American Medical Association proposed act for labeling hazardous substances; an industry look at the proposed act.
    FUESS JT
    AMA Arch Ind Health; 1959 Mar; 19(3):274-7. PubMed ID: 13626240
    [No Abstract]   [Full Text] [Related]  

  • 10. The American Medical Association proposed act for labeling hazardous substances; legal implications for industry.
    COLEMAN LA
    AMA Arch Ind Health; 1959 Mar; 19(3):271-3. PubMed ID: 13626239
    [No Abstract]   [Full Text] [Related]  

  • 11. President's page.
    Holland MH
    Radiol Technol; 1980; 52(3):293-5. PubMed ID: 7280213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testimonies on the Veterinary Public Health Workforce Expansion Act of 2007 (H.R. 1232) presented before the subcommittee on health of the United States House of Representatives Committee on Energy and Commerce, January 23, 2008.
    Pappaioanou M; Allen SW; DeHaven WR; Kelly AM
    J Vet Med Educ; 2008; 35(3):439-48. PubMed ID: 19066362
    [No Abstract]   [Full Text] [Related]  

  • 13. House subcommittee rejects effort to remove abortion coverage.
    Reprod Freedom News; 1994 May; 3(10):3-4. PubMed ID: 12319328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution for hazardous chemicals on an international level--the approach of the European project "SUBSPORT".
    Lissner L; Romano D
    New Solut; 2011; 21(3):477-97. PubMed ID: 22001043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-border impacts of the restriction of hazardous substances: a perspective based on Japanese solders.
    Fuse M; Tsunemi K
    Environ Sci Technol; 2013 Aug; 47(16):9028-34. PubMed ID: 23875815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The federal economic poison act; its effect on chemical and drug producers.
    BARTENSTEIN F
    Food Drug Cosmet Law Q; 1948 Jun; 3(2):226-36. PubMed ID: 18865044
    [No Abstract]   [Full Text] [Related]  

  • 17. Ignoring business regulations can be hazardous to your practice. Concerns facing the profession.
    Zuziak P
    J Am Vet Med Assoc; 1992 Aug; 201(3):379-80. PubMed ID: 1506239
    [No Abstract]   [Full Text] [Related]  

  • 18. Labeling legislation--a summary review of recent developments.
    FLANAGAN JE
    Am J Public Health Nations Health; 1960 May; 50(5):637-41. PubMed ID: 13823364
    [No Abstract]   [Full Text] [Related]  

  • 19. The Federal Hazardous Substances Labeling Act.
    WHEATLEY GM
    Pediatrics; 1961 Sep; 28():499-500. PubMed ID: 13784739
    [No Abstract]   [Full Text] [Related]  

  • 20. [Revised poison legislation. A proposal submitted for investigation of laws regarding poisons].
    LONNGREN R
    Sven Farm Tidskr; 1961 Aug; 65():557-62. PubMed ID: 13763392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.